CIK 0001000694 · Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222816046
- Phone
- 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 8-K Event Material agreement · Agreement ended
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 8 of 83 · 1,649 filings